TABLE 3.
Mean time‐to‐treatment initiation and time to adjuvant treatment for the patient population with Stages IA‐IIIB non‐small cell lung cancer, expressed in days
Patterns of care variable | Mean time (days) | P a | P for interaction (with time) b | ||||
---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | |||
Stages IA‐IIIA | |||||||
Lung resection surgery following diagnosis | 51.5 | 50.1 | 49.5 | 48.2 | 41.2 | .10 | .40 |
Stages IA‐IIB | |||||||
Lung resection surgery following diagnosis (sensitivity analysis) | 49.1 | 48.7 | 46.8 | 45.8 | 46.5 | .04* | 1.00 |
Stages IA‐IIIB | |||||||
Thoracic radiation following diagnosis | 74.1 | 72.7 | 74.1 | 72.2 | 70.7 | .16 | .98 |
Stages IB‐IIIA | |||||||
Platinum‐based vinorelbine adjuvant chemotherapy following surgery | 62.1 | 64.2 | 63.3 | 62.7 | 61.6 | .41 | .42 |
Q indicates income quintile.
P‐value for the multivariable regression model effect of SES and outcome, without the interaction term between socioeconomic status (SES) and time.
P‐value for the interaction term between income quintile and index year, in the multivariable regression model.
Denotes a statistically significant finding (P < .05) where P is the overall adjusted income quintile F value from multivariable linear regression.